Literature DB >> 19962178

Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.

Ghassan M Saed1, Rouba Ali-Fehmi, Zhong L Jiang, Nicole M Fletcher, Michael P Diamond, Husam M Abu-Soud, Adnan R Munkarah.   

Abstract

OBJECTIVES: Resistance to apoptosis is a key feature of cancer cells and is believed to be regulated by nitrosonium ion (NO(+))-induced S-nitrosylation of key enzymes. Nitric oxide (NO), produced by inducible nitric oxide synthase (iNOS), is utilized by MPO to generated NO(+). We sought to investigate the expression of myeloperoxidase (MPO) and iNOS in epithelial ovarian cancer (EOC) and determine their effect on S-nitrosylation of caspase-3 and its activity as well as apoptosis.
METHODS: MPO and iNOS expression were determined using immunofluorescence in SKOV-3 and MDAH-2774 and EOC tissue sections. S-nitrosylation of caspase-3 and its activity, levels of MPO and iNOS, as well as apoptosis, were evaluated in the EOC cells before and after silencing MPO or iNOS genes with specific siRNA probes utilizing real-time RT-PCR, ELISA, and TUNEL assays.
RESULTS: MPO and iNOS are expressed in EOC cell lines and in over 60% of invasive EOC cases with no expression in normal ovarian epithelium. Indeed, silencing of MPO or iNOS gene expression resulted in decreased S-nitrosylation of caspase-3, increased caspase-3 activity, and increased apoptosis but with a more significant effect when silencing MPO.
CONCLUSION: MPO and iNOS are colocalized to the same cells in EOC but not in the normal ovarian epithelium. Silencing of either MPO or iNOS significantly induced apoptosis, highlighting their role as a redox switch that regulates apoptosis in EOC. Understanding the mechanisms by which MPO functions as a redox switch in regulating apoptosis in EOC may lead to future diagnostic tools and therapeutic interventions. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962178      PMCID: PMC2834266          DOI: 10.1016/j.ygyno.2009.11.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  24 in total

Review 1.  NO: an inhibitor of cell death.

Authors:  L Liu; J S Stamler
Journal:  Cell Death Differ       Date:  1999-10       Impact factor: 15.828

2.  Nitric oxide is a physiological substrate for mammalian peroxidases.

Authors:  H M Abu-Soud; S L Hazen
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

3.  Increased myeloperoxidase and lipid peroxide-modified protein in gynecological malignancies.

Authors:  M Song; N Santanam
Journal:  Antioxid Redox Signal       Date:  2001-12       Impact factor: 8.401

4.  Nitric oxide modulates the catalytic activity of myeloperoxidase.

Authors:  H M Abu-Soud; S L Hazen
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

5.  Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.

Authors:  A R Munkarah; R Morris; P Baumann; G Deppe; J Malone; M P Diamond; G M Saed
Journal:  J Soc Gynecol Investig       Date:  2002 May-Jun

6.  Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: development of a model describing NO-peroxidase interactions.

Authors:  H M Abu-Soud; M Y Khassawneh; J T Sohn; P Murray; M A Haxhiu; S L Hazen
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

7.  Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation.

Authors:  Philip R Dash; Judith E Cartwright; Philip N Baker; Alan P Johnstone; Guy St J Whitley
Journal:  Exp Cell Res       Date:  2003-07-15       Impact factor: 3.905

8.  Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia.

Authors:  Ghassan M Saed; Michael P Diamond
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

9.  S-Nitrosylation of mitochondrial caspases.

Authors:  J B Mannick; C Schonhoff; N Papeta; P Ghafourifar; M Szibor; K Fang; B Gaston
Journal:  J Cell Biol       Date:  2001-09-10       Impact factor: 10.539

Review 10.  Regulation of the apoptosis-necrosis switch.

Authors:  Pierluigi Nicotera; Gerry Melino
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

View more
  17 in total

1.  The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride.

Authors:  Husam M Abu-Soud; Dhiman Maitra; Jaeman Byun; Carlos Eduardo A Souza; Jashoman Banerjee; Ghassan M Saed; Michael P Diamond; Peter R Andreana; Subramaniam Pennathur
Journal:  Free Radic Biol Med       Date:  2011-11-10       Impact factor: 7.376

2.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

3.  The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.

Authors:  Jimmy Belotte; Nicole M Fletcher; Awoniyi O Awonuga; Mitchell Alexis; Husam M Abu-Soud; Mohammed G Saed; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2013-09-27       Impact factor: 3.060

4.  Binding of Intracellular Myeloperoxidase to αV/β1 Integrin Serves as a Mechanism of Survival in Epithelial Ovarian Cancer.

Authors:  Amy K Harper; Thea K Kirsch-Mangu; Hala Lutfi; Robert T Morris; Ghassan M Saed
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 3.060

Review 5.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

6.  Association of myeloperoxidase with ovarian cancer.

Authors:  Dan Cacsire Castillo-Tong; Dietmar Pils; Georg Heinze; Ioana Braicu; Jalid Sehouli; Alexander Reinthaller; Eva Schuster; Andrea Wolf; Rafal Watrowski; Richard A Maki; Robert Zeillinger; Wanda F Reynolds
Journal:  Tumour Biol       Date:  2013-07-27

7.  Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.

Authors:  Rafael Soares Lindoso; Federica Collino; Giovanni Camussi
Journal:  Oncotarget       Date:  2015-04-10

8.  Comparative proteomics analysis of placenta from pregnant women with intrahepatic cholestasis of pregnancy.

Authors:  Ting Zhang; Yueshuai Guo; Xuejiang Guo; Tao Zhou; Daozhen Chen; Jingying Xiang; Zuomin Zhou
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  The Aryl hydrocarbon receptor mediates reproductive toxicity of polychlorinated biphenyl congener 126 in rats.

Authors:  Violet Klenov; Susanne Flor; Shanthi Ganesan; Malavika Adur; Nazmin Eti; Khursheed Iqbal; Michael J Soares; Gabriele Ludewig; Jason W Ross; Larry W Robertson; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

10.  A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival.

Authors:  Jimmy Belotte; Nicole M Fletcher; Mohammed G Saed; Mohammed S Abusamaan; Gregory Dyson; Michael P Diamond; Ghassan M Saed
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.